Every specification, every release decision, every CMC claim rests on analytical data — and that data is only trustworthy if the methods producing it are validated. Analytical method validation is the often-invisible foundation of GMP quality. Here is what it involves for peptides.
What is method validation?
Method validation is the documented proof that an analytical method does what it is supposed to do — reliably and reproducibly. Governed by ICH Q2, it demonstrates that a method (such as an HPLC purity assay) gives accurate, consistent results for its intended purpose. It is a core part of the framework in our GMP & quality guide and the work of our analytical sciences team.
What gets tested
- Specificity: the method measures the target without interference from impurities.
- Accuracy: results are close to the true value.
- Precision: repeatable within and between analysts and days.
- Linearity & range: reliable across the relevant concentrations.
- Limits of detection / quantitation: the smallest amounts reliably seen and measured.
- Robustness: tolerance to small, deliberate changes in conditions.
Key point: an unvalidated method is an opinion. Validation turns it into evidence a regulator can rely on.
Why it matters for peptides
Peptides bring specific analytical challenges — closely-related deletion impurities, counterion and water content, and identity confirmation by mass spectrometry. Methods must be specific enough to resolve them, which is why method development and validation go hand in hand with purification and specification setting.
Where validated methods are used
Validated methods underpin batch release, support every batch record, transfer cleanly during tech transfer, and form a key part of the CMC section of a regulatory filing. They are, quite literally, how you prove your peptide is what you say it is.